Recalcitrant pyoderma gangrenosum—two cases successfully treated with cyclosporin A

Clinical and Experimental Dermatology

Volumn 17, Issue 1, 1992, Pages 49-52

  KAVANAGH, G M ^a   ROSS, J S ^a   CRONTN, E ^a   SMITH, N P ^a   BLACK, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MINOCYCLINE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; CASE REPORT; CYCLOSPORINE; FEMALE; HUMAN; MIDDLE AGE; PYODERMA;

EID: 0026585538     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1992.tb02535.x     Document Type: Article

References (25)

1. Cyclosporin A: Review of results in organ and bone transplantation in man
2. Cyclosporine in Dermatology
3. Pyoderma gangrenosum treated with Cyclosporin A
4. Cyclosporine Therapy for pyoderma gangrenosum associated with sclecrosing cholangitis and ulcerative
5. Pyoderma gangrenosum: Response to Cyclosporin A
6. Treatment of recalcitrant pyoderma gangrenosum with Cyclosporine
7. Effective treatment of pyoderma gangrenosum with Cyclosporin: A report of five cases
8. Pyoderma gangrenosum: successful treatment with Minocycline
9. Pyoderma gangrenosum: A reappraisal of associated systemic diseases
10. Pyoderma gangrenosum: Clinical and laboratory findings in 15 patients with special reference to polyarthritis
11. Low does Cyclosporin versus placebo in patients with rheumatoid arthritis
12. Commentary; Pyoderma gangrenosum
13. Pyoderma ganprenosum; abnormal monocyte function corrected in vitro with hydrocortisone
14. Pyoderma gangrenosum
15. Pyoderma gangrenosum treated with Azathioprine and Prednisolone
16. Pyoderma gangrenosum treated with 6 Mercaptopurine and followed by acute leukaemia
17. The inhibition of polymorphonuclear leucocyte toxicity by Dapsone
18. Clofazimine in the treatment of pyoderma gangrenosum
19. Cyclosporin in autoimmune disease
20. Cyclosporin A mediates immunosuppression of primary cytotoxic T‐cell responses by impairing the release of interleukin 1 and interleukin 2
21. Sparing of suppressor cells; A critical action of Cyclosporin
22. Action and toxicity of Cyclosporin
23. Nephrotoxicity in patients with rheumatoid arthritis treated with Cyclosporine
24. Side effects of systemic Cyclosporine in patients not undergoing transplantation
25. Intralesional cyclosporine in the treatment of psoriasis